Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies.

Source:http://linkedlifedata.com/resource/pubmed/id/12368351

Download in:

View as

General Info

PMID
12368351